A forum for researchers, students and applicants in the field of cyclodextrin technology
A group of researchers employed by different subsidiaries of Janssen Research & Development, Scripps Research Institute, Department of Epidemiology, as well
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical
In the recent two weeks, Cyclolab had the pleasure to welcome two prominent pioneers of cyclodextrin research, Prof. Loftsson from
There is a not extremely recent but certainly very interesting patent application related to a special use of cyclodextrins, namely
Amgen announced on the 27th August, 2018 the submission of a supplemental New Drug Application (sNDA) to the U.S. Food
Prof. Thorsteinn Loftsson (University of Iceland) explains in his lecture on the website of CyclonHit project the mechanism how drugs
The video of Prof. Thorsteinn Loftsson on the website of CyclonHit project gives the basic information on the effect of
The video of Prof. Thorsteinn Loftsson on the website of CycloHit project gives a summary on the physicochemical and pharmacokinetic
If you are following advances in the re-discovery of cyclodextrins as APIs, there is quite a race among the candidates
The application of cyclodextrins as excipients is wellspread, common knowledge worldwide. Their application as APIs is getting huge publicity, developments
